Ixekizumab Treatment Patterns and Health Care Resource Utilization Among Patients with Axial Spondyloarthritis: A Retrospective United States Claims Database Study
Abstract Introduction Real-world data on ixekizumab utilization in axial spondyloarthritis (axSpA) are limited. We evaluated ixekizumab treatment patterns and health care resource utilization (HCRU) in patients with axSpA using United States Merative L.P. MarketScan® Claims Databases. Methods This r...
| Published in: | Rheumatology and Therapy |
|---|---|
| Main Authors: | Abhijeet Danve, Aisha Vadhariya, Jeffrey Lisse, Arjun Cholayil, Neha Bansal, Natalia Bello, Catherine Bakewell |
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2024-08-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40744-024-00710-0 |
Similar Items
Efficacy of Ixekizumab in Chinese Patients with Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level
by: Ning Kong, et al.
Published: (2025-05-01)
by: Ning Kong, et al.
Published: (2025-05-01)
Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events
by: Mark Lebwohl, et al.
Published: (2025-01-01)
by: Mark Lebwohl, et al.
Published: (2025-01-01)
Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial Spondyloarthritis
by: Xiaoxia Zhu, et al.
Published: (2024-06-01)
by: Xiaoxia Zhu, et al.
Published: (2024-06-01)
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks
by: Helena Marzo-Ortega, et al.
Published: (2020-08-01)
by: Helena Marzo-Ortega, et al.
Published: (2020-08-01)
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials
by: Atul Deodhar, et al.
Published: (2024-02-01)
by: Atul Deodhar, et al.
Published: (2024-02-01)
An update on the management of axial spondyloarthritis for sports medicine professionals
by: Abhijeet Danve, et al.
Published: (2024-10-01)
by: Abhijeet Danve, et al.
Published: (2024-10-01)
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis
by: Walter P. Maksymowych, et al.
Published: (2024-06-01)
by: Walter P. Maksymowych, et al.
Published: (2024-06-01)
Differential diagnosis of axial spondyloarthritis and psoriatic arthritis with axial involvement
by: E. E. Gubar, et al.
Published: (2025-06-01)
by: E. E. Gubar, et al.
Published: (2025-06-01)
Comparison of osteoporosis frequency in female patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis
by: Bekir Torun, et al.
Published: (2024-07-01)
by: Bekir Torun, et al.
Published: (2024-07-01)
Comparative characteristics of axial spondyloarthritis and psoriatic arthritis with axial involvement
by: Е. Е. Gubar, et al.
Published: (2024-04-01)
by: Е. Е. Gubar, et al.
Published: (2024-04-01)
Editorial: Clinical manifestations and comorbidities in axial and peripheral spondyloarthritis
by: Ruxandra Elena Schiotis, et al.
Published: (2022-08-01)
by: Ruxandra Elena Schiotis, et al.
Published: (2022-08-01)
Saudi Clinical Practice Guidelines for Management of Axial Spondyloarthritis Disease
by: Hanan Al Rayes, et al.
Published: (2025-07-01)
by: Hanan Al Rayes, et al.
Published: (2025-07-01)
Resolution of the Expert Council “New approaches to the treatment of axial spondyloarthritis”
by: A. M. Lila, et al.
Published: (2024-06-01)
by: A. M. Lila, et al.
Published: (2024-06-01)
COMPARATIVE ANALYSIS OF MAIN CLINICAL MANIFESTATIONS IN MALES AND FEMALES WITH EARLY AXIAL SPONDYLOARTHRITIS
by: D. G. Rumyantseva, et al.
Published: (2019-09-01)
by: D. G. Rumyantseva, et al.
Published: (2019-09-01)
«FLARES» IN AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-07-01)
by: Sh. F. Erdes
Published: (2016-07-01)
Axial Spondyloarthritis: An Evolving Concept
by: Nelly Ziadé
Published: (2015-07-01)
by: Nelly Ziadé
Published: (2015-07-01)
Axial spondyloarthritis: a current look at the concept and evolution of the disease
by: D. G. Rumyantseva, et al.
Published: (2019-10-01)
by: D. G. Rumyantseva, et al.
Published: (2019-10-01)
Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort
by: Regula Neuenschwander, et al.
Published: (2020-10-01)
by: Regula Neuenschwander, et al.
Published: (2020-10-01)
Patients with Axial Spondyloarthritis are Great Consumers of Healthcare Resources, Especially Young and Women: Results from the Spanish Atlas
by: Marco Garrido-Cumbrera, et al.
Published: (2023-03-01)
by: Marco Garrido-Cumbrera, et al.
Published: (2023-03-01)
Biologics and biosimilars in axial spondyloarthritis: Lots of kids on the block!
by: Concepcion Castillo-Gallego, et al.
Published: (2020-01-01)
by: Concepcion Castillo-Gallego, et al.
Published: (2020-01-01)
Spondyloarthritis in India
by: Anand N Malaviya
Published: (2020-01-01)
by: Anand N Malaviya
Published: (2020-01-01)
Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum
by: Francisca Sivera, et al.
Published: (2023-05-01)
by: Francisca Sivera, et al.
Published: (2023-05-01)
Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab
by: A. Egeberg, et al.
Published: (2022-07-01)
by: A. Egeberg, et al.
Published: (2022-07-01)
Features of the course and outcomes of COVID-19 in patients with axial spondyloarthritis
by: Sh. F. Erdes
Published: (2022-07-01)
by: Sh. F. Erdes
Published: (2022-07-01)
Extracellular matrix protein turnover markers are associated with axial spondyloarthritis—a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back pain
by: Helena Port, et al.
Published: (2022-06-01)
by: Helena Port, et al.
Published: (2022-06-01)
Korean treatment recommendations for patients with axial spondyloarthritis
by: Mi Ryoung Seo, et al.
Published: (2023-09-01)
by: Mi Ryoung Seo, et al.
Published: (2023-09-01)
Temporomandibular Internal Derangements Denote Activity of Axial Spondyloarthritis
by: Ana-Marija Laškarin, et al.
Published: (2025-01-01)
by: Ana-Marija Laškarin, et al.
Published: (2025-01-01)
Corrigendum: Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum
by: Francisca Sivera, et al.
Published: (2024-09-01)
by: Francisca Sivera, et al.
Published: (2024-09-01)
Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials
by: Toussirot E, et al.
Published: (2016-07-01)
by: Toussirot E, et al.
Published: (2016-07-01)
Results of a non-interventional multicenter study of management of patients with non-radiological axial spondyloarthritis in real-life clinical practice in the Russian Federation (NiSpAR)
by: T. V. Dubinina, et al.
Published: (2024-04-01)
by: T. V. Dubinina, et al.
Published: (2024-04-01)
Radiologic methods as a tool for monitoring axial spondyloarthritis in real clinical practice
by: T. V. Dubinina, et al.
Published: (2022-02-01)
by: T. V. Dubinina, et al.
Published: (2022-02-01)
Ixekizumab
by: İlgen Ertam Sağduyu
Published: (2022-04-01)
by: İlgen Ertam Sağduyu
Published: (2022-04-01)
Anti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort
by: Janneke J. de Winter, et al.
Published: (2018-03-01)
by: Janneke J. de Winter, et al.
Published: (2018-03-01)
ASSESSMENT OF COXITIS PROGRESSION IN EARLY AXIAL SPONDYLOARTHRITIS
by: E. M. Agafonova, et al.
Published: (2020-04-01)
by: E. M. Agafonova, et al.
Published: (2020-04-01)
Advices for diagnostics of ankylosing spondylitis / axial spondyloarthritis: A review Part 2. Spinal column involvement
by: Nikolay V. Bunchuk, et al.
Published: (2024-05-01)
by: Nikolay V. Bunchuk, et al.
Published: (2024-05-01)
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
by: A. Spadaro, et al.
Published: (2013-07-01)
by: A. Spadaro, et al.
Published: (2013-07-01)
Association Between Diagnostic Delay and Economic and Clinical Burden in Axial Spondyloarthritis: A Multicentre Retrospective Observational Study
by: Laura Berbel-Arcobé, et al.
Published: (2025-01-01)
by: Laura Berbel-Arcobé, et al.
Published: (2025-01-01)
Disease activity and two-year sacroiliac joint changes according to instrumental study findings in a CoRSAr cohort of patients with early axial spondyloarthritis
by: Sh. Erdes, et al.
Published: (2019-05-01)
by: Sh. Erdes, et al.
Published: (2019-05-01)
Progression of axial spondyloarthritis
by: Sh. F. Erdes, et al.
Published: (2021-06-01)
by: Sh. F. Erdes, et al.
Published: (2021-06-01)
Ixekizumab: an alternative for HIV-positive psoriasis patients
by: Fanghua Liu, et al.
Published: (2024-11-01)
by: Fanghua Liu, et al.
Published: (2024-11-01)
Similar Items
-
Efficacy of Ixekizumab in Chinese Patients with Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level
by: Ning Kong, et al.
Published: (2025-05-01) -
Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events
by: Mark Lebwohl, et al.
Published: (2025-01-01) -
Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial Spondyloarthritis
by: Xiaoxia Zhu, et al.
Published: (2024-06-01) -
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks
by: Helena Marzo-Ortega, et al.
Published: (2020-08-01) -
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials
by: Atul Deodhar, et al.
Published: (2024-02-01)
